QUANTITATIVE DETERMINATION OF 5‐S‐CYSTEINYLDOPA, DOPA AND DOPAMINE IN THE URINE BY MEANS OF HIGH‐PERFORMANCE LIQUID CHROMATOGRAPHY

By  

THE JOURNAL OF DERMATOLOGY, Vol. 8, Iss. 4, 1981-08 ,pp. : 301-304

John Wiley & Sons Inc

Access to resources Recommend Favorite

DETECTION AND QUANTITATION OF 5‐S‐CYSTEINYLDOPA IN MELANOTIC AND AMELANOTIC MELANOMA IN COMPARISON WITH NONPIGMENT CELL TUMORS AND IT'S URINARY EXCRETION

By  

THE JOURNAL OF DERMATOLOGY, Vol. 6, Iss. 6, 1979-12 ,pp. : 379-382

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum 5‐S‐Cysteinyldopa (5‐S‐CD) as a Marker of Melanoma Progression

By  

THE JOURNAL OF DERMATOLOGY, Vol. 19, Iss. 11, 1992-11 ,pp. : 809-813

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum Concentration of 5‐S‐Cysteinyldopa in Pediatric Patients with Giant Pigmented Nevi

By  

THE JOURNAL OF DERMATOLOGY, Vol. 23, Iss. 1, 1996-01 ,pp. : 16-21

John Wiley & Sons Inc

Access to resources Recommend Favorite

TYROSINASE AND γ‐GLUTAMYL TRANSPEPTIDASE IN 5‐S‐CYSTEINYLDOPA GENESIS WITHIN MELANOTIC AND AMELANOTIC MELANOMAS

By  

THE JOURNAL OF DERMATOLOGY, Vol. 9, Iss. 1, 1982-02 ,pp. : 73-77

John Wiley & Sons Inc

Access to resources Recommend Favorite